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Abstract
Aim of the research is studying the pecularities of the endometrium pathological processes in postmenopausal women on 
the basis of the hysteroscopy data evaluation, as well as conduction of histopathological and immunochemical studies.
Materials and methods. To study the pecularities of intrauterine pathological processes, 100 postmenopausal women were 
selected and studied. All women underwent hysteroscopy with separate diagnostic scraping of the uterine cavity. Also, 10 samples of 
glandular-fibrous endometrial polyps (GFEP) in women of reproductive age and 9 samples of such pathology in the postmenopausal 
period were studied by immunohistochemical method, using 6 primary specific monoclonal antibodies. 
Results. The results showed that in 64 (64 %) postmenopausal women pathological changes of the endometrium were pre-
sented with GFEP, and in 2 patients (2 %) endometrial adenocarcinoma was found. It was also determined that the nuclei of epithelial 
and stromal cells of GFEP in postmenopausal women are characterized by lower expression of estrogen and progesterone receptors, 
compared with women with such formations in the reproductive age. In addition, it was found that in postmenopausal women the 
expression of the apoptosis inhibitor bcl-2 and aromatase P450 in the epithelial and stromal cells of GFEP was more expressed, and 
the expression of the Bах antigen, on the contrary, was significantly lower than in women of reproductive age. 
Conclusions. Fundamental molecular-biological differences of GFEP in postmenopausal women compared with women of 
reproductive age were revealed. It was found that in postmenopausal women there is a significantly lower dependence of such polyps 
on the effects of estrogen and progesterone. In addition, the data indicate an increased risk of neoplastic transformation in such women.




Problems of the postmenopausal period, in particular prevention, diagnosis and treatment of 
endometrial pathology in elderly patients, have become especially relevant in gynecology. Elderly 
women are at risk for a variety of intrauterine pathology on the background of involutive changes 
in the reproductive system. Pathological processes of the endometrium (PPE) in such women are 
cha racterized by a high risk of malignancy and problems associated with dysfunctional uterine 
bleeding and anemia [1, 2]. Thus, according to various studies, about 50 % of cases of endometrial 
cancer in postmenopause are the result of malignancy of endometrial hyperplastic processes. The 
frequency and timing of malignancy vary widely and largely depend on the severity of hyperpro-
liferation in the endometrium, the presence of hormonal and metabolic disorders. It is also known 
that the risk of PPE malignancy is 2.5 times higher in women whose menstrual function ended after 
50 years, compared with women whose menopause occurred before 50 years [3, 4].
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In addition, it was found that hyper- and neoplastic processes in the uterine mucosa develop 
against the background of a progressive decrease in the ability of cells to apoptosis and increase 
the intensity of neoangiogenesis. Therefore, much attention is paid to proteins of the bcl-2 family, 
which can promote or inhibit apoptosis by synthesizing antiapoptotic (namely bcl-2, bcl-Xl) or 
proapoptotic (for example, Bах, Bак, Bad, Bid, bcl-X) proteins and others [5, 6].
In the majority of postmenopausal women, PPE is asymptomatic, which does not exclude 
the presence of a pathological process in the involutive endometrium and which are detected only 
during ultrasound diagnostics [7, 8]. Therefore, the diagnosis of PPE in the postmenopausal period, 
in particular on the basis of histopathological and immunochemical studies, remain relevant in 
modern medicine. 
The aim is to study the features of pathological processes of the endometrium in postmeno-
pausal women on the basis of evaluation of hysteroscopy data, as well as conduction of the histo-
pathological and immunochemical studies.
2. Materials and methods
The study was conducted from 2017 to 2019 on the basis of the Department of Obstetrics, 
Gynecology and Perinatology of Shupyk National Healthcare University of Ukraine, on the basis 
of the Municipal Non-Profit Enterprise «Vinnytsia Central District Clinical Hospital», as well as 
on the pathomorphology department of State Institution «Institute Of Pediatrics, Obstetrics And 
Gynecology» Named After Academician O.M. Lukyanova of the National Academy Of Medical 
Sciences Of Ukraine.
In order to analyze the features of intrauterine pathological processes in the postmenopaus-
al period, 100 women were selected. The age of patients ranged from 60 to 85 years (mean age 
68.5 ± 5.7 years). The period when menopause occurred ranged from 42 to 57 years. The average 
menopause occurred at the age of 47.8 ± 5.7.
The study was conducted in accordance with the Helsinki Declaration according to the conclu-
sion of the Ethics Commission of Shupyk National Healthcare University of Ukraine (Protocol No. 3 
from 07.02.2017). Informed consent to participate in the study was obtained from all women.
From the anamnesis it was established that 10 women (10 %) did not become pregnant, 
40 women (40 %) had one childbirth, 35 patients (35 %) had two and 15 women (15 %) had three 
or more births. 
From the gynecological anamnesis it was found that 20 women (20 %) had uterine fibroids, 
30 patients (30 %) had endometrial pathology, 25 women (25 %) had cervical pathology and pelvic 
inflammatory disease (PID), and 10 women (10 %) – ovarian cysts.
All patients admitted to the gynecology department with suspected PPE were routinely 
examined. At the outpatient stage, they underwent a complete clinical and laboratory examina-
tion, including complaint analysis, detailed history taking, gynecological examination, blood type, 
rhesus factor, RW, HIV, HBsAg, HCV, clinical blood test, general urine test, biochemical blood 
test, coagulogram, smears on flora and urogenital infections, smears on oncocytology of the 
cervix, ECG, chest radiography. 
In addition to general clinical, all patients underwent gynecological examination, including 
examination of the external genitalia, cervix in mirrors with simple and advanced colposcopy, 
bimanual examination to determine the position, size, density, motility of the uterus and append-
ages, depth and nature of discharge.
Hysteroscopy with separate-diagnostic scraping of the cervical canal and uterine cavity was 
performed in the gynecological department in a small operating room under general short-term 
intravenous anesthesia. When performing diagnostic and therapeutic hysteroscopy operating and 
contact hysteroscope «Olympus 4 mm» was used. The outer diameter of the hysteroscopes was 
8 mm, the corresponding telescopes had a diameter of 4 mm. Turusol, sterile saline and 5 % glu-
cose solution were used as liquid media. Separate diagnostic scraping of the cervical canal and 
uterine cavity was performed under aseptic conditions after treatment of the external genitalia 
and vaginal mucosa with 1 % solution of iodopyrone, the cervix was grasped with ball forceps. 
Dilation of the cervical canal was performed using Gegar dilators up to No. 9. The cervical canal 
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was scraped with a curette No. 1, then the uterine cavity was scraped with a No. 2, 4, 6 curette. 
Scrapers were placed in separate plastic containers, and then sent to the pathology department. The 
material for optical examination was fixed in 10 % neutral formalin, carried out through alcohols of 
increasing concentration (50–96°), poured into histomyx, and then on a rotary microtome Sakura 
made sections 5–6 μm thick, which were waxed and stained with hematoxylin and eosin .
Immunohistochemical study of 10 samples of GFEP in women of reproductive age (10 ob-
servations) and menopause (9 patients aged 64–81 years), using 6 primary specific monoclonal 
antibodies, namely: to estrogen receptors (rabbit monoclonal antibody, IgG, C-term, Spring Bio-
science, USA); to progesterone receptors (rabbit monoclonal antibody, IgG, C-term, Spring Bio-
science, USA); to Ki-67 protein (mouse monoclonal antibody, IgG1, Leica, UK); to the apoptosis 
inhibitor bcl-2 (Bcl-2, mouse monoclonal antibody, IgGl, Cell Marque, USA); to the apoptosis 
inducer Bax (Bax-antibody, rabbit monoclonal antibody, IgG, GeneTex, USA); to cytochrome 450 
aromatase (cytochrome 450 – rabbit monoclonal antibody, IgG, GeneTex, USA) was conducted. 
The results were evaluated by calculating the expression coefficients of an antigen.
The 2007 Microsoft Office package, in particular Excel 2007, was used for the statistical 
analysis of the obtained results. Evaluation of the statistical significance of the obtained data was 
performed using Student’s t-test. The differences were considered statistically significant at p < 0.05.
3. Results of the research
The obtained results showed that out of 100 postmenopausal women with suspected PPE 
during gynecological examination, 11 women (11 %) had atresia of the external pharynx, another 
ten (10 %) had atresia of the internal pharynx detected during uterine probing during surgery.
All women underwent separate diagnostic scraping of the cervical canal and uterine cavity 
with prior hysteroscopy. Thus, the hysteroscopic picture of the uterine cavity in such women was 
characterized by the presence of polyps of different size and location, inhomogeneous local thick-
ening of the endometrium, the presence of submucosal or interstitial submucosal fibroids, syne-
chiae in the uterine cavity, signs of endometrial atrophy and chronic endometritis.
14 patients (14 %) underwent surgical hysteroscopy using endoscopic forceps and scis-
sors (removal of small polyps from the tube angles), 11 women (11 %) underwent hysteroresecto-
scopy (removal of fibroids and polyps on a broad basis, which could not be removed by curettage), 
as well as 6 patients (6 %) endometrial ablation was conducted. 
Pathohistological examination of 70 (70 %) patients revealed pathological changes in the 
endometrium. In addition, in 25 (25 %) women only atrophy of the endometrium, and in 5 (5 %) – 
submucosal nodes of uterine fibroids (Table 1) were histologically determined.
Table 1
The structure of PPE in postmenopausal women
Nosological unit Abs. %
No pathological changes were detected, atrophic endometrium 25 25 %
Glandular-fibrous endometrial polyp 64 64 %
Chronic endometritis 4 4 %
Endometrial adenocarcinoma 2 2 %
Submucosal nodes 5 5 %
Total 100 100 %
Thus, most often PPE in postmenopausal women was characterized by glandular-fibrous 
polyps (64 %, namely in 64 patients). At the same time, there were a high percentage of atrophic 
processes of the endometrium, which was due to age-related changes, as well as a high frequency 
of malignant endometrial tumors.
In order to further analyze of GFEP, as the most important pathology in the structure of 
PPE, the examined women underwent immunohistochemical study. For this purpose, 6 primary 
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specific monoclonal antibodies to estrogen receptors, progesterone, Ki-67 protein, bcl-2 apoptosis 
inhibitor and apoptosis inducer Bax were used. Their expression by epithelial and stromal cells of 
GFEP was compared between women in the postmenopausal and reproductive periods. 
Analysis of the obtained data showed that in postmenopausal women the expression of es-
trogen and progesterone receptors by the nuclei of epithelial and stromal cells of GFEP was statis-
tically significantly lower compared to women of reproductive age (Table 2).
Table 2
Expression coefficients (M ± m) of estrogen and progesterone receptors by the nuclei of epithelial and stromal 
cells of GFEP
Indicator
Women of reproductive age (n = 10) Postmenopausal women (n = 9)
Epithelium Stroma Epithelium Stroma
Estrogen receptors expression 2.04 ± 0.06 1.53 ± 0.09 1.03 ± 0.07* 0.61 ± 0.05*
Progesterone receptors expression 0.87 ± 0.09 1.12 ± 0.05 0.42 ± 0.04* 0.53 ± 0.06*
Note: * – p < 0.01 compared with GFEP indices in women of reproductive age
In the study of Ki-67 expression, it was found that for all studied GFEP, regardless of age 
and period of life of women, the expression of the marker of proliferation in the glandular epithe-
lium was similar, namely proliferative activity was significantly expressed in both observation 
groups. However, in contrast to GFEP in the reproductive period, in such polyps in postmenopausal 
women, the expression of Ki-67 in the nuclei of stromal cells was more expressed (Table 3).
Table 3
Coefficient of expression (M ± m) of Ki-67 by the nuclei of epithelial and stromal cells of GFEP
Indicator
Women of reproductive age (n = 10) Postmenopausal women (n = 9)
Epithelium Stroma Epithelium Stroma
Kі-67 expression 0.55 ± 0.13 0.39 ± 0.11 0.48 ± 0.04 0.65 ± 0.01*
Note: * – p < 0.05 compared with GFEP indices in women of reproductive age
The level of such an indicator as a bcl-2 apoptosis inhibitor was also determined. Thus, in 
comparison with GFEP in women of reproductive age, in polyps of postmenopausal women, its 
expression in epithelial and stromal cells was more expressed (Table 4).
Table 4
Coefficients of expression (M ± m) of apoptosis inhibitor bcl-2 by epithelial and stromal cells of GFEP
Indicator
Women of reproductive age (n = 10) Postmenopausal women (n = 9)
Epithelium Stroma Epithelium Stroma
bcl-2 expression 0.22 ± 0.02 0.11 ± 0.01 0.49 ± 0.04* 0.38 ± 0.03*
Note: * – p < 0.01 compared with GFEP indices in women of reproductive age
With regard to the expression of the inducer of apoptosis, the Bax antigen, in polyps in 
postmenopausal women, its expression in epithelial and stromal cells was much weaker (Table 5). 
Thus, the processes of apoptosis in GFEP in postmenopausal women are significantly suppressed, 
in contrast to GFEP in women of reproductive age. As a result, despite the absence of statistically 
significant differences in the proliferative activity of the epithelium and its increase only in the 









Expression coefficients (M ± m) of the apoptosis inducer (Bax) by epithelial and stromal cells of GFEP
Indicator
Women of reproductive age (n = 10) Postmenopausal women (n = 9)
Epithelium Stroma Epithelium Stroma
Вах expression 0.68 ± 0.05 0.62 ± 0.05 0.38 ± 0.04* 0.33 ± 0.03*
Note: * – p < 0.001 compared with GFEP indices in women of reproductive age
In addition to the above indicators, the expression of aromatase P450 was also evaluated. 
Thus, in comparison with GFEP in the reproductive period, with polyps in postmenopausal women 
in varying degrees, from minimal to moderate, there was a expressed expression, but mainly in the 
epithelium of the glands (Table 6). This is a fundamental difference between GFEP in postmeno-
pause, which indicates the local synthesis of estrogen in such polyps. 
Table 6
Coefficient of expression (M ± m) of aromatase P450 by epithelial and stromal cells of GFEP
Indicator
Women of reproductive age (n = 10) Postmenopausal women (n = 9)
Epithelium Stroma Epithelium Stroma
Р450 expression – – 0.12 ± 0.02* 0.09 ± 0.01*
Note: * – p < 0.01 compared with GFEP indices in women of reproductive age
Thus, the results obtained by immunohistochemical study showed that postmenopausal 
women with GFEP, in contrast to such pathology in the reproductive period, are characterized 
by less influence of estrogen and progesterone on the development of such polyps. The study also 
found an increased risk of neoplastic transformation in postmenopausal women.
4. Discussion
The hormonal background of the female body changes throughout life – from early re-
productive age to postmenopause. According to the available data, the changes that occur during 
premenopause, menopause and postmenopause can cause various pathological processes of the 
endometrium. Such processes require considerable attention and timely diagnosis, as they can lead 
to the development of cancer. The cause of such disorders is usually called hormonal imbalance, in 
particular the development of hyperestrogenism, as well as a progressive decrease in the ability of 
cells to apoptosis and increase the intensity of neoangiogenesis [9, 10].
In this context, it should be noted that the pathology of the endometrium is one of the disea-
ses that is more common in postmenopausal women. Thus, according to a number of studies, in 
particular [11, 12], such pathology in 90 % of cases occurs in women over 50 years of age. In ad-
dition, a number of researchers indicate that PPE in such women are mainly represented by endo-
metrial polyps, submucosal uterine fibroids, chronic endometritis, synechiae. Also, compared with 
women of reproductive age, endometrial adenocarcinoma is more common [13, 14].
As a result of the histopathological examination the following structure of PPE was revealed: 
glandular-fibrous endometrial polyp – 64 %, or in 64 women; atrophic endometrium – 25 %, or in 
25 patients; submucosal nodes – 5 %, or in 5 patients; chronic endometritis – 4 %, or in 4 women; 
endometrial adenocarcinoma – 2 %, or in 2 women.
In order to study the peculiarities of the development of such processes and their comparison 
in different periods, namely in postmenopause and reproductive age, to increase the effectiveness 
of their early diagnosis, an in-depth immunohistochemical study of GFEP, as a disorder occupying 
the largest share, were conducted. 
Given that the causes of PPE may be absolute and relative hyperestrogenism with corre-
sponding changes in progesterone levels, and, at the same time, the lack of unambiguous data on 
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the role of these processes in the postmenopausal period in the development of GFEP, comparison 
of the expression of estrogen receptors and progesterone stromal cells in women of postmenomasal 
and reproductive age was conducted. 
Analysis of the data showed that the expression of estrogen receptors was statistically sig-
nificantly lower in postmenopausal women compared with women of reproductive age. A similar 
pattern was observed with respect to the expression of progesterone receptors, namely its signifi-
cantly lower expression by the nuclei of epithelial and stromal cells of GFEP in the postmenopausal 
period, compared with women of reproductive age.
The development of PPE also depends on the characteristics of the proliferative activity of 
the endometrium, which is facilitated by proliferation factors, in particular Ki-67, which are nec-
essary for the replication of genomic DNA. At the same time, in the literature there are debatable 
data on changes in the proliferation factor of Ki-67 in hyperplasia compared with normal endome-
trium, in particular on the differences between postmenopause and reproductive age [15, 16]. The 
results of the study showed that its proliferative activity was significantly expressed in both groups. 
At the same time, in the nuclei of GFEP stromal cells in postmenopausal women, the expression of 
Ki-67 was more significant, in contrast to GFEP in women of reproductive age.
In addition to proliferative factors, the development of PPE is also influenced by antiapop-
totic, especially bcl-2, and proapoptotic, in particular Bax, proteins that act as inhibitors or inducers 
of apoptosis. In this context, there is a hypothesis that polyps are not essentially mitotically hyper-
active, but develop due to a defect in the mechanisms of natural control of apoptosis, which leads 
to prolonged cell life [17, 18].
The results of the study showed that in comparison with GFEP patients of reproductive age, 
in polyps of postmenopausal women, the expression of bcl-2 in epithelial and stromal cells was 
significantly higher. Another picture was observed for the Вах antigen, which was characterized 
by significantly lower expression in the epithelial and stromal cells of GFEP in postmenopausal 
women than in polyps in women of reproductive age [19].
The local increase in the estrogen concentration, which enhances cell proliferation, indi-
cates the expression of aromatase cytochrome 450. Under conditions of apoptosis suppression, this 
increases the risk of neoplastic transformation [20, 21]. The obtained data showed the presence of 
such expression in GFEP of postmenopausal women, in contrast to such formations in women 
of reproductive age.
Study limitations. The study did not include women who had acute infectious diseases and 
women with severe extragenital diseases who were contraindicated surgeries under anesthesia.
Prospects for further research. Improving the effectiveness of early diagnosis of PPE in 
postmenopausal women to reduce the risk of their malignant transformation. 
5. Conclusions
The results obtained during the study made it possible to identify the anatomical features of 
the uterus in the postmenopausal period, in particular partial or complete atresia of the cervical canal.
It was also found that the most common pathology of the endometrium in postmenopausal 
women are glandular-fibrous endometrial polyps (64 %, namely in 64 women), and there is a high 
risk of endometrial adenocarcinoma (2 %, namely in 2 women).
The obtained data of immunohistochemical study showed that in GFEP patients in post-
menopausal period there was a statistically significant lower expression of both estrogen receptors 
and progesterone. At the same time, the expression of Ki-67, which is responsible for proliferative 
activity, was significantly expressed in both women of reproductive age and postmenopausal wom-
en. It was also found that the expression of the proliferation marker Ki-67 in the nuclei of stromal 
cells was more expressed in the postmenopausal period than in the reproductive age.
In addition to the mentioned above, there was an increase in the expression of the apoptosis 
inhibitor bcl-2 along with a decrease in the expression of the inducer of apoptosis Bax in the epi-
thelial and stromal cells of polyps in postmenopausal women compared with reproductive age. The 
results indicate that the processes of apoptosis in GFEP in postmenopausal women are significant-
ly suppressed, compared with GFEP in women of reproductive age. Cytochrome 450 aromatase 
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expression was also found to be higher than that of women of reproductive age, indicating the 
likelihood of a local increase in estrogen levels, which in turn will increase cell proliferation. All 
this together with the suppression of apoptosis may increase the risk of neoplastic transformation. 
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